This guideline covers assessing and managing low back pain and sciatica in people aged 16 and over.
Scilex Holding Company , a Sorrento Company, announced pivotal Phase III Semdexa data presentation at the American Society of Interventional Pain 2022 annual meeting.
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic...
Scilex Holding Company , a majority-owned subsidiary of Sorrento Therapeutics, Inc. announced highly significant positive final results from its SP 102 (Semdexa) Phase III Pivotal Trial C.L.E.A.R. Program. SP 102 (Semdexa) has received Fast Track status from the FDA.
Scilex Holding Company, a commercial-stage, non-opioid biopharmaceutical pain management company, announces highly significant positive top-line results from its Phase III SP-102 (Semdexa) Pivotal Trial C.L.E.A.R Program for its novel, non-opioid, corticosteroid formulation, injectable dexamethasone sodium phosphate viscous gel product for the treatment of lumbosacral radicular pain (sciatica).
Ferring Pharmaceuticals announced that it has signed an agreement with Seikagaku Corporation granting Ferring the exclusive worldwide rights (excluding Japan)...
This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice...
Codeine is indicated in patients older than 12 years of age for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen alone. Solpadeine Max Tablets are recommended for the relief of migraine, headache, dental pain, period pain, backache, arthritic & rheumatic pain, strains & sprains and sciatica.
Codeine is indicated in patients older than 12 years of age for the short term treatment of acute moderate pain which is not relieved by paracetamol, ibuprofen or aspirin alone. This medicine is recommended for the relief of migraine, headache, backache, rheumatic pain, period pain, dental pain, strains and sprains and sciatica.
Codeine is indicated in patients older than 12 years for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen alone. Solpadeine Plus Capsules are recommended for the relief of migraine, headache, backache, rheumatic pain, period pains, dental pain, strains & sprains and sciatica.